Posted by Mr.Scott on December 7, 2002, at 1:34:58
In reply to Re: Lexapro and headaches » Jaycee, posted by pharmrep on December 4, 2002, at 9:10:19
Thank you for the information. I have forwarded it to the advertising
division for their evaluation.Jim Morrison
CDER Ombudsman
--------------------------------------------------------------------------------
Subj: Forest Pharmaceuticals
Date: Wed, 4 Dec 2002 04:06:23 -0500
From:
To: MORRISONJ@CDER.FDA.GOVDear Mr. Morrison of the DDMAC division of the FDA,
There is a well trafficked forum for patients suffering mental illness on
the
internet at the address www.dr-bob.org/babble.Under the posting name of "pharmrep," you will find a self-admitting
representative for Forest Pharmaceuticals who is disseminating clinical data
directly to patients on the newly approved SSRI
Lexapro (escitalopram).I believe this constitutes a marketing violation in that a self admitting
pharmaceutical representative for Forest Pharmaceuticals is 'selling' or consulting
directly to patients without any clear fair balance attached to the information
being so readily offered. As I understand the regulatory procedure all direct to patient marketing must contain clear fair balance.While this clever marketing tactic of creating hopes in the minds of the
suffering with the ultimate goal of influencing physicians prescibing
habbits
may not yet have a legal precendent by which your body can make a
deliberation, I think it is worthy of investigation.Sincerely and Annonymous.
poster:Mr.Scott
thread:109458
URL: http://www.dr-bob.org/babble/20021203/msgs/130863.html